Published in J Clin Invest on September 01, 1994
The metabolic syndrome. Endocr Rev (2008) 5.33
Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest (1996) 4.98
Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest (1999) 3.18
Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia (2010) 3.17
Role of body fat distribution and the metabolic complications of obesity. J Clin Endocrinol Metab (2008) 3.05
Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res (2010) 2.87
Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest (1996) 2.82
Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest (1997) 2.57
Life history of eNOS: partners and pathways. Cardiovasc Res (2007) 2.53
Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications. Rev Endocr Metab Disord (2010) 2.19
Insulin resistance of muscle protein metabolism in aging. FASEB J (2006) 2.17
Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag (2005) 2.15
The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action. Diabetologia (2009) 2.11
Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. Cell Metab (2010) 2.09
Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag (2007) 1.88
Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk. J Clin Invest (1997) 1.88
Abnormal skeletal muscle capillary recruitment during exercise in patients with type 2 diabetes mellitus and microvascular complications. J Am Coll Cardiol (2009) 1.71
Oxidative stress in early diabetic nephropathy: fueling the fire. Nat Rev Endocrinol (2010) 1.51
Aerobic exercise overcomes the age-related insulin resistance of muscle protein metabolism by improving endothelial function and Akt/mammalian target of rapamycin signaling. Diabetes (2007) 1.50
Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature. Am J Physiol Endocrinol Metab (2011) 1.48
Effect of insulin on human skeletal muscle protein synthesis is modulated by insulin-induced changes in muscle blood flow and amino acid availability. Am J Physiol Endocrinol Metab (2006) 1.46
Increased CYP2J3 expression reduces insulin resistance in fructose-treated rats and db/db mice. Diabetes (2010) 1.27
Hormonal modulation of endothelial NO production. Pflugers Arch (2010) 1.26
Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2008) 1.24
Vascular effects of exercise: endothelial adaptations beyond active muscle beds. Physiology (Bethesda) (2011) 1.24
The vascular effects of L-Arginine in humans. The role of endogenous insulin. J Clin Invest (1997) 1.22
Childhood obesity-related endothelial dysfunction: an update on pathophysiological mechanisms and diagnostic advancements. Pediatr Res (2016) 1.19
Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1. J Clin Invest (1998) 1.17
Dimethylarginine dimethylaminohydrolase overexpression enhances insulin sensitivity. Arterioscler Thromb Vasc Biol (2008) 1.16
Insulin resistance in the vasculature. J Clin Invest (2013) 1.16
Obesity blunts microvascular recruitment in human forearm muscle after a mixed meal. Diabetes Care (2009) 1.15
Pathogenesis and pathophysiology of the cardiometabolic syndrome. J Clin Hypertens (Greenwich) (2009) 1.14
Pharmacological vasodilation improves insulin-stimulated muscle protein anabolism but not glucose utilization in older adults. Diabetes (2010) 1.13
Increased endothelial nitric-oxide synthase expression reduces hypertension and hyperinsulinemia in fructose-treated rats. J Pharmacol Exp Ther (2008) 1.13
Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes. Int J Vasc Med (2012) 1.12
Insulin infusion in acute illness. J Clin Invest (2005) 1.10
Insulin reduces plasma arginase activity in type 2 diabetic patients. Diabetes Care (2007) 1.10
Role of blood flow in regulating insulin-stimulated glucose uptake in humans. Studies using bradykinin, [15O]water, and [18F]fluoro-deoxy-glucose and positron emission tomography. J Clin Invest (1996) 1.07
Early diabetic neuropathy: triggers and mechanisms. World J Gastroenterol (2007) 1.06
Effects of insulin on adipose tissue blood flow in man. J Physiol (2002) 1.05
Progressive hyperglycemia across the glucose tolerance continuum in older obese adults is related to skeletal muscle capillarization and nitric oxide bioavailability. J Clin Endocrinol Metab (2011) 1.02
Impaired endothelial function in healthy African-American adolescents compared with Caucasians. J Pediatr (2007) 1.02
Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm. J Clin Invest (1997) 1.01
Coming full circle in diabetes mellitus: from complications to initiation. Nat Rev Endocrinol (2013) 1.01
Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans. Am J Physiol Regul Integr Comp Physiol (2008) 1.00
Insulin inhibits low oxygen-induced ATP release from human erythrocytes: implication for vascular control. Microcirculation (2009) 1.00
Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity. J Clin Invest (1998) 1.00
Insulin and the arginine paradox. J Clin Invest (1997) 0.98
Insulin induces the release of vasodilator compounds from platelets by a nitric oxide-G kinase-VAMP-3-dependent pathway. J Exp Med (2004) 0.97
Muscle microvascular blood flow responses in insulin resistance and ageing. J Physiol (2015) 0.97
New insights into insulin action and resistance in the vasculature. Ann N Y Acad Sci (2014) 0.97
C-reactive protein causes insulin resistance in mice through Fcγ receptor IIB-mediated inhibition of skeletal muscle glucose delivery. Diabetes (2012) 0.96
APPL1 counteracts obesity-induced vascular insulin resistance and endothelial dysfunction by modulating the endothelial production of nitric oxide and endothelin-1 in mice. Diabetes (2011) 0.96
Coronary microvascular dysfunction in diabetes mellitus: A review. World J Cardiol (2010) 0.96
Interleukin-6 impairs the insulin signaling pathway, promoting production of nitric oxide in human umbilical vein endothelial cells. Mol Cell Biol (2007) 0.95
Epoxyeicosatrienoic acids mediate insulin-mediated augmentation in skeletal muscle perfusion and blood volume. Am J Physiol Endocrinol Metab (2014) 0.94
New insights into insulin: The anti-inflammatory effect and its clinical relevance. World J Diabetes (2014) 0.94
Inhibition of insulin signaling in endothelial cells by protein kinase C-induced phosphorylation of p85 subunit of phosphatidylinositol 3-kinase (PI3K). J Biol Chem (2011) 0.93
Insulin resistance, metabolic stress, and atherosclerosis. Front Biosci (Schol Ed) (2012) 0.93
Intact insulin stimulation of skeletal muscle blood flow, its heterogeneity and redistribution, but not of glucose uptake in non-insulin-dependent diabetes mellitus. J Clin Invest (1997) 0.92
Muscle perfusion: its measurement and role in metabolic regulation. Diabetes (2012) 0.92
The metabolic syndrome and the heart--a considered opinion. Clin Res Cardiol (2006) 0.92
GLP-1, the gut-brain, and brain-periphery axes. Rev Diabet Stud (2011) 0.91
Activity restriction, impaired capillary function, and the development of insulin resistance in lean primates. Am J Physiol Endocrinol Metab (2012) 0.91
The endothelial cell: an "early responder" in the development of insulin resistance. Rev Endocr Metab Disord (2013) 0.90
Cell signalling-mediating insulin increase of mRNA expression for cationic amino acid transporters-1 and -2 and membrane hyperpolarization in human umbilical vein endothelial cells. Pflugers Arch (2004) 0.90
Prognostic value of endothelial dysfunction in type 1 diabetes mellitus. World J Diabetes (2014) 0.89
The vascular endothelium in diabetes--a therapeutic target? Rev Endocr Metab Disord (2013) 0.89
Severe impairment of endothelial function with the HIV-1 protease inhibitor indinavir is not mediated by insulin resistance in healthy subjects. Cardiovasc Toxicol (2008) 0.89
Development of a new Sonovue™ contrast-enhanced ultrasound approach reveals temporal and age-related features of muscle microvascular responses to feeding. Physiol Rep (2013) 0.89
Induction of insulin resistance by high-sucrose feeding does not raise mean arterial blood pressure but impairs haemodynamic responses to insulin in rats. Br J Pharmacol (2002) 0.88
Whole body vibration training improves leg blood flow and adiposity in patients with type 2 diabetes mellitus. Eur J Appl Physiol (2013) 0.88
Insulin resistance, obesity, hypertension, and renal sodium transport. Int J Hypertens (2011) 0.87
Neuronal nitric oxide synthase is phosphorylated in response to insulin stimulation in skeletal muscle. Biochem Biophys Res Commun (2013) 0.87
The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study. Cardiovasc Diabetol (2011) 0.87
Hyperinsulinemia fails to augment ET-1 action in the skeletal muscle vascular bed in vivo in humans. Am J Physiol Endocrinol Metab (2008) 0.87
Impaired insulin-mediated vasorelaxation in diabetic Goto-Kakizaki rats is caused by impaired Akt phosphorylation. Am J Physiol Cell Physiol (2008) 0.87
Glycine propionyl-L-carnitine produces enhanced anaerobic work capacity with reduced lactate accumulation in resistance trained males. J Int Soc Sports Nutr (2009) 0.86
Insulin resistance and skeletal muscle vasculature: significance, assessment and therapeutic modulators. Cardiorenal Med (2014) 0.85
Regulation of obesity and insulin resistance by nitric oxide. Free Radic Biol Med (2014) 0.85
eNOS phosphorylation on serine 1176 affects insulin sensitivity and adiposity. Biochem Biophys Res Commun (2013) 0.85
Differential vasomotor effects of insulin on gastrocnemius and soleus feed arteries in the OLETF rat model: role of endothelin-1. Exp Physiol (2013) 0.85
Muscle protein metabolism responds similarly to exogenous amino acids in healthy younger and older adults during NO-induced hyperemia. Am J Physiol Regul Integr Comp Physiol (2011) 0.85
Tissue inflammation and nitric oxide-mediated alterations in cardiovascular function are major determinants of endotoxin-induced insulin resistance. Cardiovasc Diabetol (2015) 0.85
Brain GLP-1 signaling regulates femoral artery blood flow and insulin sensitivity through hypothalamic PKC-δ. Diabetes (2011) 0.85
Skeletal muscle insulin resistance in salt-sensitive hypertension: role of angiotensin II activation of NFκB. Cardiovasc Diabetol (2015) 0.85
Elevated D-glucose induces insulin insensitivity in human umbilical endothelial cells isolated from gestational diabetic pregnancies. J Physiol (1998) 0.84
A variation in NOS1AP gene is associated with repaglinide efficacy on insulin resistance in type 2 diabetes of Chinese. Acta Pharmacol Sin (2010) 0.84
Toll-like receptor 2 mediates high-fat diet-induced impairment of vasodilator actions of insulin. Am J Physiol Endocrinol Metab (2013) 0.84
Hypertension in metabolic syndrome: vascular pathophysiology. Int J Hypertens (2013) 0.84
Influence of insulin and glargine on outgrowth and number of circulating endothelial progenitor cells in type 2 diabetes patients: a partially double-blind, randomized, three-arm unicenter study. Cardiovasc Diabetol (2014) 0.83
Transcorneal electrical stimulation increases chorioretinal blood flow in normal human subjects. Clin Ophthalmol (2010) 0.82
Role of lipotoxicity in endothelial dysfunction. Heart Fail Clin (2012) 0.82
Cardiovascular impact of drugs used in the treatment of diabetes. Ther Adv Chronic Dis (2014) 0.82
Intensive insulin treatment improves forearm blood flow in critically ill patients: a randomized parallel design clinical trial. Crit Care (2009) 0.82
Body fat and sympathetic nerve activity. Cardiovasc Drugs Ther (1996) 0.82
The metabolic syndrome and risk of chronic kidney disease: pathophysiology and intervention strategies. J Nutr Metab (2012) 0.81
Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study. Cardiovasc Diabetol (2013) 0.81
Angiotensin-(1-7) recruits muscle microvasculature and enhances insulin's metabolic action via mas receptor. Hypertension (2014) 0.81
Nutritionally essential amino acids and metabolic signaling in aging. Amino Acids (2012) 0.80
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (1980) 40.02
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (1987) 35.44
Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A (1989) 8.34
L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun (1988) 7.77
Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet (1989) 7.69
Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med (1990) 5.91
Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol (1988) 3.88
Insulin resistance in essential hypertension. N Engl J Med (1987) 3.78
Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest (1990) 3.74
Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol (1988) 3.54
Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest (1991) 3.49
Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia (1992) 3.43
Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci U S A (1991) 3.22
The relation of adiposity to blood pressure and development of hypertension. The Framingham study. Ann Intern Med (1967) 3.05
Skeletal muscle blood flow. A possible link between insulin resistance and blood pressure. Hypertension (1993) 2.51
L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest (1992) 2.35
Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest (1992) 2.26
Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes (1992) 2.16
Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens (1992) 1.77
Skeletal muscle blood flow independently modulates insulin-mediated glucose uptake. Am J Physiol (1994) 1.74
Effects of peptides and non-peptides on isolated arterial smooth muscles: role of endothelium. Eur J Pharmacol (1985) 1.64
Euglycemic hyperinsulinemia augments amino acid uptake by human leg tissues during hyperaminoacidemia. Am J Physiol (1990) 1.60
Beta adrenergic-mediated vasodilator response to insulin in the human forearm. J Pharmacol Exp Ther (1985) 1.52
Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension (1993) 1.48
Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest (1993) 1.45
Angiotensin II increases glucose utilization during acute hyperinsulinemia via a hemodynamic mechanism. J Clin Invest (1993) 1.22
Glucose storage and oxidation in different degrees of human obesity measured by continuous indirect calorimetry. Diabetologia (1981) 1.10
Modulation of endothelium-dependent responses by chronic alterations of blood flow. Am J Physiol (1986) 1.09
Independent stimulation of glucose metabolism and Na+-K+ exchange by insulin in the human forearm. Am J Physiol (1988) 1.09
Enhanced release of endothelium-derived factor(s) by chronic increases in blood flow. Am J Physiol (1988) 1.08
Modulation of NO and endothelin by chronic increases in blood flow in canine femoral arteries. Am J Physiol (1992) 1.04
Effects of L-arginine on forearm vessels and responses to acetylcholine. Hypertension (1992) 1.04
Cholinergic vasodilator nerves. Fed Proc (1967) 1.02
Role of prostaglandin H2 as an endothelium-derived contracting factor in diabetic state. Diabetes (1993) 0.99
Insulin-stimulated vascular relaxation. Role of Ca(2+)-ATPase. Am J Hypertens (1992) 0.90
Enhanced release of endothelium-derived relaxing factor in mineralocorticoid hypertension. Hypertension (1992) 0.89
Insulin sensitivity and hypertension. J Hypertens Suppl (1990) 0.89
Insulin does not reduce forearm alpha-vasoreactivity in obese hypertensive or lean normotensive men. Hypertension (1993) 0.85
Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab (2000) 11.97
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest (1996) 4.98
Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials. Trop Med Int Health (2004) 4.35
Mechanism of action of the cro protein of bacteriophage lambda. Proc Natl Acad Sci U S A (1978) 4.34
Hereditary hemochromatosis. Phenotypic expression of the disease. N Engl J Med (1979) 4.09
The Temperature of the Human Skin. Proc Natl Acad Sci U S A (1919) 4.00
Genetic linkage between hereditary hemochromatosis and HLA. Am J Hum Genet (1979) 3.96
Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol (1988) 3.84
Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest (1990) 3.74
Exonuclease III and endonuclease IV remove 3' blocks from DNA synthesis primers in H2O2-damaged Escherichia coli. Proc Natl Acad Sci U S A (1986) 3.72
Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax (1980) 3.70
Ethics approval for a national postal survey: recent experience. BMJ (1995) 3.59
Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol (1988) 3.54
Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet (2005) 3.38
Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int (2007) 3.23
Case-control study of intrapartum care, cerebral palsy, and perinatal death. BMJ (1994) 3.00
The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med (1990) 2.82
Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill (2008) 2.78
Automatic disposable stapling devices for wound closure. Ann Emerg Med (1981) 2.77
Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest (1997) 2.57
Skeletal muscle blood flow. A possible link between insulin resistance and blood pressure. Hypertension (1993) 2.51
Antenatal microbiologic and maternal risk factors associated with prematurity. Am J Obstet Gynecol (1990) 2.44
Acid-base status at birth and neurodevelopmental outcome at four and one-half years. Am J Obstet Gynecol (1989) 2.38
Cryptogenic fibrosing alveolitis and lung cancer. Thorax (1980) 2.31
Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival. Thorax (1980) 2.27
Endothelial dysfunction is associated with cholesterol levels in the high normal range in humans. Circulation (1997) 2.26
Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes (1992) 2.16
A regional register of early childhood impairments: a discussion paper. The Steering Committee of the Oxford Region Child Development Project. Community Med (1989) 2.14
Prevalence and severity of feeding and nutritional problems in children with neurological impairment: Oxford Feeding Study. Dev Med Child Neurol (2000) 2.06
Patient empowerment in secondary prevention of coronary heart disease. Lancet (2000) 2.03
Adenotonsillectomy in children: a comparison of morphine and fentanyl for peri-operative analgesia. Anaesthesia (2001) 2.01
HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP). Diabetes Care (2001) 1.99
Vascular function, insulin resistance and fatty acids. Diabetologia (2002) 1.97
Prevalence of obesity in American Indians and Alaska Natives. Am J Clin Nutr (1991) 1.92
Broadening access to undergraduate medical education. BMJ (2000) 1.85
Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: comparison with mefloquine, doxycycline, and chloroquine plus proguanil. J Infect Dis (1995) 1.83
Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N Engl J Med (1992) 1.82
Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest (1998) 1.82
Neonatal risk factors for cerebral palsy in very preterm babies: case-control study. BMJ (1997) 1.81
Educational and behavioural problems in babies of 32-35 weeks gestation. Arch Dis Child Fetal Neonatal Ed (2001) 1.80
Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology (2002) 1.79
Chicken epidermal growth factor (EGF) receptor: cDNA cloning, expression in mouse cells, and differential binding of EGF and transforming growth factor alpha. Mol Cell Biol (1988) 1.77
Evaluation of immunomagnetic separation for recovery of infectious Cryptosporidium parvum oocysts from environmental samples. Appl Environ Microbiol (1999) 1.76
Skeletal muscle blood flow independently modulates insulin-mediated glucose uptake. Am J Physiol (1994) 1.74
Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. J Clin Invest (1996) 1.72
Repeatability characteristics of simple indices of insulin resistance: implications for research applications. J Clin Endocrinol Metab (2001) 1.71
Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes (2000) 1.71
Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. J Clin Invest (1995) 1.71
Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B. J Natl Cancer Inst (1996) 1.70
Insulin resistance after hypertension induced by the nitric oxide synthesis inhibitor L-NMMA in rats. Am J Physiol (1995) 1.68
Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int (1998) 1.64
Ketoconazole retains activity in advanced prostate cancer patients with progression despite flutamide withdrawal. J Urol (1997) 1.63
Primary care physicians' practice patterns and diabetic retinopathy. Current levels of care. Arch Fam Med (1997) 1.62
The Sweet syndrome during therapy with granulocyte colony-stimulating factor. Ann Intern Med (1992) 1.59
Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes (2000) 1.59
Assessing the prevalence and determinants of unwanted pregnancy and induced abortion in Nigeria. Stud Fam Plann (1999) 1.58
Comparative studies of nucleic acid hybridization assay for Listeria in foods. J Assoc Off Anal Chem (1988) 1.58
Length of stay of acute psychiatric inpatients: an exponential model. Acta Psychiatr Scand (1995) 1.55
Cerebral palsy and neonatal encephalopathy. Arch Dis Child Fetal Neonatal Ed (1994) 1.55
International, collaborative assessment of 146,000 prenatal karyotypes: expected limitations if only chromosome-specific probes and fluorescent in-situ hybridization are used. Hum Reprod (1999) 1.54
The contribution of low birth weight to severe vision loss in a geographically defined population. Br J Ophthalmol (1998) 1.54
Costing neonatal care alongside the Collaborative ECMO trial: how much primary research is required? Health Econ (1996) 1.53
Clustering of perinatal markers of birth asphyxia and outcome at age five years. Br J Obstet Gynaecol (1994) 1.52
Diabetic foot infections. Bacteriologic analysis. Arch Intern Med (1986) 1.51
Structure-function analysis of a novel member of the LIV-1 subfamily of zinc transporters, ZIP14. FEBS Lett (2005) 1.50
Proteolysis in skeletal muscle and whole body in response to euglycemic hyperinsulinemia in normal adults. Am J Physiol (1991) 1.50
Interaction between insulin sensitivity and muscle perfusion on glucose uptake in human skeletal muscle: evidence for capillary recruitment. Diabetes (2000) 1.49
The quality of impressions for crowns and bridges received at commercial dental laboratories. Br Dent J (1997) 1.49
Patterns of outpatient prescription drug use among Pennsylvania elderly. Health Care Financ Rev (1991) 1.49
THE ACTION OF STREPTOCOCCAL DESOXYRIBOSE NUCLEASE (STREPTODORNASE)IN VITRO AND ON PURULENT PLEURAL EXUDATIONS OF PATIENTS. J Clin Invest (1949) 1.49
The involvement of general practitioners in the care of patients with human immunodeficiency virus infection: current practice and future implications. Fam Pract (1993) 1.47
An assessment of urodynamic examination in incontinent women. Br J Obstet Gynaecol (1980) 1.47
Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome. Diabetes Care (1999) 1.46
Linkage of Gordon's syndrome to the long arm of chromosome 17 in a region recently linked to familial essential hypertension. J Hum Hypertens (1998) 1.45
"Folate before pregnancy": the impact on women and health professionals of a population-based health promotion campaign in South Australia. Med J Aust (2001) 1.45
Trends among pathogens reported as causing bacteraemia in England, 2004-2008. Clin Microbiol Infect (2011) 1.44
Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996-1998. Acta Paediatr Suppl (2000) 1.44
Inhibitory and anti-inflammatory effects of the Helicobacter pylori-derived antimicrobial peptide HPA3NT3 against Propionibacterium acnes in the skin. Br J Dermatol (2014) 1.43
Garlic ingestion by pregnant women alters the odor of amniotic fluid. Chem Senses (1995) 1.43
Changes in total RNA, polyadenylated RNA, and actin mRNA during meiotic maturation of mouse oocytes. Dev Biol (1985) 1.43
Metal-ceramic bridges from commercial dental laboratories: alloy composition, cost and quality of fit. Br Dent J (1992) 1.42
Randomised trial of early tapping in neonatal posthaemorrhagic ventricular dilatation: results at 30 months. Arch Dis Child (1994) 1.41
Ability of primary care physicians to make accurate ratings of psychiatric symptoms. Arch Gen Psychiatry (1982) 1.41
The effects of Scaphoid and Colles casts on hand function. J Hand Surg Br (2006) 1.41
Comparison of single photon emission computed tomography findings in cases of healthy adults and solvent-exposed adults. Am J Ind Med (1997) 1.40
Metabolic response to oral challenge of hydrogenated starch hydrolysate versus glucose in diabetes. Diabetes Care (1990) 1.40
Risk factors associated with preterm delivery after fetoscopic laser ablation for twin-twin transfusion syndrome. Ultrasound Obstet Gynecol (2014) 1.40
Apolipoprotein (a) and ischaemic heart disease. Lancet (1990) 1.39